At least five collaborations seeking to discover diabetes candidates that promote beta cell regeneration have been announced since 2009. Drug candidates discovered in the 2011 collaboration among Evotec AG (Xetra:EVT), Harvard University and Howard Hughes Medical Institute were licensed this month to the Janssen Pharmaceuticals Inc. subsidiary of Johnson & Johnson